Global Cord Blood (NYSE:CO) Shares Cross Above Two Hundred Day Moving Average – Time to Sell?

Global Cord Blood Co. (NYSE:COGet Free Report)’s share price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.92 and traded as high as $0.9505. Global Cord Blood shares last traded at $0.9505, with a volume of 5,003 shares traded.

Global Cord Blood Price Performance

The stock has a market cap of $121.55 million, a price-to-earnings ratio of 1.56 and a beta of 0.16. The business’s 50 day moving average is $0.97 and its 200 day moving average is $0.92.

Global Cord Blood Company Profile

(Get Free Report)

Global Cord Blood Corporation (NYSE: CO) is a leading operator of umbilical cord blood banking services in the People’s Republic of China. The company provides critical stem cell preservation and related services through its network of cord blood banks and medical partners. Its core activities encompass the collection, processing, testing, and long-term storage of cord blood units, which are preserved for potential therapeutic use in the treatment of hematological and genetic disorders.

In addition to cord blood banking, Global Cord Blood offers supplemental clinical services such as viability testing, stem cell expansion research, and personalized consultation for expectant parents.

Further Reading

Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.